Vatalanib

• Description:

  A potent, orally available class III receptor tyrosine kinases inhibitor with IC50 of <1 uM for VEGFR, Flt-1, KDR and PDGFRβ.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  419.7348

• Molecular Formula:

  C20H17Cl3N4

• Notes:

  Research use only, not for human use.

• Receptor:

  PDGFRβ|VEGFR1/FLT1|VEGFR2/Flk1|VEGFR2/KDR|VEGFR3/FLT4

• CAS Number:

  212141-51-0